We've found
						6,982
						 archived clinical trials in
						Endocrine
					
				We've found
						6,982
						 archived clinical trials in
						Endocrine
	
	Versartis Trial in Children to Assess Long-Acting Growth Hormone
	
Updated: 5/6/2013
  
  
  A Long-acting Human Growth Hormone (VRS-317) in Pre-pubertal Children With Growth Hormone Deficiency: A Randomized, Open-label, Multi-center, Phase 1b/2a Study of Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD) and Efficacy After Subcutaneous Administration for 6 Months
		Status: Enrolling	
	Updated: 5/6/2013
	
	Versartis Trial in Children to Assess Long-Acting Growth Hormone
	
Updated: 5/6/2013
  
  
  	  A Long-acting Human Growth Hormone (VRS-317) in Pre-pubertal Children With Growth Hormone Deficiency: A Randomized, Open-label, Multi-center, Phase 1b/2a Study of Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD) and Efficacy After Subcutaneous Administration for 6 Months
		Status: Enrolling	
	Updated: 5/6/2013
Click here to add this to my saved trials
		    
			
	Versartis Trial in Children to Assess Long-Acting Growth Hormone
	
Updated: 5/6/2013
  
  
  A Long-acting Human Growth Hormone (VRS-317) in Pre-pubertal Children With Growth Hormone Deficiency: A Randomized, Open-label, Multi-center, Phase 1b/2a Study of Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD) and Efficacy After Subcutaneous Administration for 6 Months
		Status: Enrolling	
	Updated: 5/6/2013
	
	Versartis Trial in Children to Assess Long-Acting Growth Hormone
	
Updated: 5/6/2013
  
  
  	  A Long-acting Human Growth Hormone (VRS-317) in Pre-pubertal Children With Growth Hormone Deficiency: A Randomized, Open-label, Multi-center, Phase 1b/2a Study of Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD) and Efficacy After Subcutaneous Administration for 6 Months
		Status: Enrolling	
	Updated: 5/6/2013
Click here to add this to my saved trials
		    
			
	Versartis Trial in Children to Assess Long-Acting Growth Hormone
	
Updated: 5/6/2013
  
  
  A Long-acting Human Growth Hormone (VRS-317) in Pre-pubertal Children With Growth Hormone Deficiency: A Randomized, Open-label, Multi-center, Phase 1b/2a Study of Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD) and Efficacy After Subcutaneous Administration for 6 Months
		Status: Enrolling	
	Updated: 5/6/2013
	
	Versartis Trial in Children to Assess Long-Acting Growth Hormone
	
Updated: 5/6/2013
  
  
  	  A Long-acting Human Growth Hormone (VRS-317) in Pre-pubertal Children With Growth Hormone Deficiency: A Randomized, Open-label, Multi-center, Phase 1b/2a Study of Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD) and Efficacy After Subcutaneous Administration for 6 Months
		Status: Enrolling	
	Updated: 5/6/2013
Click here to add this to my saved trials
		    
			
	Effects of Naturally Silicon-Rich Water on Bone Metabolism in Women
	
Updated: 5/8/2013
  
  
  Effects of Naturally Occurring Silicon in Drinking Water on Bone Metabolism
		Status: Enrolling	
	Updated: 5/8/2013
	
	Effects of Naturally Silicon-Rich Water on Bone Metabolism in Women
	
Updated: 5/8/2013
  
  
  	  Effects of Naturally Occurring Silicon in Drinking Water on Bone Metabolism
		Status: Enrolling	
	Updated: 5/8/2013
Click here to add this to my saved trials
		    
			
	Adult Growth Hormone Deficiency and Cardiovascular Risk
	
Updated: 5/14/2013
  
  
  Assessment of Cardiovascular Risk Markers in GH Deficient Patients With Nonsecreting Pituitary Adenomas
		Status: Enrolling	
	Updated: 5/14/2013
	
	Adult Growth Hormone Deficiency and Cardiovascular Risk
	
Updated: 5/14/2013
  
  
  	  Assessment of Cardiovascular Risk Markers in GH Deficient Patients With Nonsecreting Pituitary Adenomas
		Status: Enrolling	
	Updated: 5/14/2013
Click here to add this to my saved trials
		    
			
	A Study of Adalimumab to Treat Sarcoidosis of the Skin
	
Updated: 5/20/2013
  
  
  A Double-Blind, Randomized, Placebo-Controlled Study of Adalimumab in the Treatment of Cutaneous Sarcoidosis
		Status: Enrolling	
	Updated: 5/20/2013
	
	A Study of Adalimumab to Treat Sarcoidosis of the Skin
	
Updated: 5/20/2013
  
  
  	  A Double-Blind, Randomized, Placebo-Controlled Study of Adalimumab in the Treatment of Cutaneous Sarcoidosis
		Status: Enrolling	
	Updated: 5/20/2013
Click here to add this to my saved trials
		    
			
	Effects of Aerobic Exercise in Patients With Pre-diabetes
	
Updated: 5/20/2013
  
  
  The Effect of Controlled Aerobic Exercise on Endothelial Dysfunction and Vascular Reactivity in Patients With Pre-diabetes: A Crossover Pilot Study
		Status: Enrolling	
	Updated: 5/20/2013
	
	Effects of Aerobic Exercise in Patients With Pre-diabetes
	
Updated: 5/20/2013
  
  
  	  The Effect of Controlled Aerobic Exercise on Endothelial Dysfunction and Vascular Reactivity in Patients With Pre-diabetes: A Crossover Pilot Study
		Status: Enrolling	
	Updated: 5/20/2013
Click here to add this to my saved trials
		    
			
	Adrenocorticotropic Hormone (ACTH) Treatment of Nephrotic Range Proteinuria in Diabetic Nephropathy (NRDN)
	
Updated: 5/30/2013
  
  
  "Safety and Efficacy of Acthar Gel on Albuminuria and Urinary Transforming Growth Factor Excretion in Type I or Type II Diabetics Requiring Medical Treatment of Hyperglycemia With Nephrotic Range Proteinuria: A Pilot Study"
		Status: Enrolling	
	Updated: 5/30/2013
	
	Adrenocorticotropic Hormone (ACTH) Treatment of Nephrotic Range Proteinuria in Diabetic Nephropathy (NRDN)
	
Updated: 5/30/2013
  
  
  	  "Safety and Efficacy of Acthar Gel on Albuminuria and Urinary Transforming Growth Factor Excretion in Type I or Type II Diabetics Requiring Medical Treatment of Hyperglycemia With Nephrotic Range Proteinuria: A Pilot Study"
		Status: Enrolling	
	Updated: 5/30/2013
Click here to add this to my saved trials
		    
			
	Evaluation of Patient Reported Outcome Instruments in Celiac Disease Patients
	
Updated: 5/30/2013
  
  
  Clinical Evaluation of Three Celiac Disease-Specific Patient Reported Outcome Instruments in Established and Newly Diagnosed Celiac Disease Patients
		Status: Enrolling	
	Updated: 5/30/2013
	
	Evaluation of Patient Reported Outcome Instruments in Celiac Disease Patients
	
Updated: 5/30/2013
  
  
  	  Clinical Evaluation of Three Celiac Disease-Specific Patient Reported Outcome Instruments in Established and Newly Diagnosed Celiac Disease Patients
		Status: Enrolling	
	Updated: 5/30/2013
Click here to add this to my saved trials
		    
			
	Evaluation of Patient Reported Outcome Instruments in Celiac Disease Patients
	
Updated: 5/30/2013
  
  
  Clinical Evaluation of Three Celiac Disease-Specific Patient Reported Outcome Instruments in Established and Newly Diagnosed Celiac Disease Patients
		Status: Enrolling	
	Updated: 5/30/2013
	
	Evaluation of Patient Reported Outcome Instruments in Celiac Disease Patients
	
Updated: 5/30/2013
  
  
  	  Clinical Evaluation of Three Celiac Disease-Specific Patient Reported Outcome Instruments in Established and Newly Diagnosed Celiac Disease Patients
		Status: Enrolling	
	Updated: 5/30/2013
Click here to add this to my saved trials
		    
			
	Evaluation of Patient Reported Outcome Instruments in Celiac Disease Patients
	
Updated: 5/30/2013
  
  
  Clinical Evaluation of Three Celiac Disease-Specific Patient Reported Outcome Instruments in Established and Newly Diagnosed Celiac Disease Patients
		Status: Enrolling	
	Updated: 5/30/2013
	
	Evaluation of Patient Reported Outcome Instruments in Celiac Disease Patients
	
Updated: 5/30/2013
  
  
  	  Clinical Evaluation of Three Celiac Disease-Specific Patient Reported Outcome Instruments in Established and Newly Diagnosed Celiac Disease Patients
		Status: Enrolling	
	Updated: 5/30/2013
Click here to add this to my saved trials
		    
			
	Evaluation of Patient Reported Outcome Instruments in Celiac Disease Patients
	
Updated: 5/30/2013
  
  
  Clinical Evaluation of Three Celiac Disease-Specific Patient Reported Outcome Instruments in Established and Newly Diagnosed Celiac Disease Patients
		Status: Enrolling	
	Updated: 5/30/2013
	
	Evaluation of Patient Reported Outcome Instruments in Celiac Disease Patients
	
Updated: 5/30/2013
  
  
  	  Clinical Evaluation of Three Celiac Disease-Specific Patient Reported Outcome Instruments in Established and Newly Diagnosed Celiac Disease Patients
		Status: Enrolling	
	Updated: 5/30/2013
Click here to add this to my saved trials
		    
			
	Evaluation of Patient Reported Outcome Instruments in Celiac Disease Patients
	
Updated: 5/30/2013
  
  
  Clinical Evaluation of Three Celiac Disease-Specific Patient Reported Outcome Instruments in Established and Newly Diagnosed Celiac Disease Patients
		Status: Enrolling	
	Updated: 5/30/2013
	
	Evaluation of Patient Reported Outcome Instruments in Celiac Disease Patients
	
Updated: 5/30/2013
  
  
  	  Clinical Evaluation of Three Celiac Disease-Specific Patient Reported Outcome Instruments in Established and Newly Diagnosed Celiac Disease Patients
		Status: Enrolling	
	Updated: 5/30/2013
Click here to add this to my saved trials
		    
			
	Evaluation of Patient Reported Outcome Instruments in Celiac Disease Patients
	
Updated: 5/30/2013
  
  
  Clinical Evaluation of Three Celiac Disease-Specific Patient Reported Outcome Instruments in Established and Newly Diagnosed Celiac Disease Patients
		Status: Enrolling	
	Updated: 5/30/2013
	
	Evaluation of Patient Reported Outcome Instruments in Celiac Disease Patients
	
Updated: 5/30/2013
  
  
  	  Clinical Evaluation of Three Celiac Disease-Specific Patient Reported Outcome Instruments in Established and Newly Diagnosed Celiac Disease Patients
		Status: Enrolling	
	Updated: 5/30/2013
Click here to add this to my saved trials
		    
			
	Evaluation of Patient Reported Outcome Instruments in Celiac Disease Patients
	
Updated: 5/30/2013
  
  
  Clinical Evaluation of Three Celiac Disease-Specific Patient Reported Outcome Instruments in Established and Newly Diagnosed Celiac Disease Patients
		Status: Enrolling	
	Updated: 5/30/2013
	
	Evaluation of Patient Reported Outcome Instruments in Celiac Disease Patients
	
Updated: 5/30/2013
  
  
  	  Clinical Evaluation of Three Celiac Disease-Specific Patient Reported Outcome Instruments in Established and Newly Diagnosed Celiac Disease Patients
		Status: Enrolling	
	Updated: 5/30/2013
Click here to add this to my saved trials
		    
			
	Evaluation of Patient Reported Outcome Instruments in Celiac Disease Patients
	
Updated: 5/30/2013
  
  
  Clinical Evaluation of Three Celiac Disease-Specific Patient Reported Outcome Instruments in Established and Newly Diagnosed Celiac Disease Patients
		Status: Enrolling	
	Updated: 5/30/2013
	
	Evaluation of Patient Reported Outcome Instruments in Celiac Disease Patients
	
Updated: 5/30/2013
  
  
  	  Clinical Evaluation of Three Celiac Disease-Specific Patient Reported Outcome Instruments in Established and Newly Diagnosed Celiac Disease Patients
		Status: Enrolling	
	Updated: 5/30/2013
Click here to add this to my saved trials
		    
			
	Evaluation of Patient Reported Outcome Instruments in Celiac Disease Patients
	
Updated: 5/30/2013
  
  
  Clinical Evaluation of Three Celiac Disease-Specific Patient Reported Outcome Instruments in Established and Newly Diagnosed Celiac Disease Patients
		Status: Enrolling	
	Updated: 5/30/2013
	
	Evaluation of Patient Reported Outcome Instruments in Celiac Disease Patients
	
Updated: 5/30/2013
  
  
  	  Clinical Evaluation of Three Celiac Disease-Specific Patient Reported Outcome Instruments in Established and Newly Diagnosed Celiac Disease Patients
		Status: Enrolling	
	Updated: 5/30/2013
Click here to add this to my saved trials
		    
			
	An Study to Investigate the Recovery, Excretion, and Pharmacokinetics of 14C-GSK1265744 Administered as a Single Oral Dose and a Study to Describe the Pharmacokinetics of a Supratherapeutic Dose of GSK1265744 in Healthy Adult Subjects
	
Updated: 5/30/2013
  
  
  An Open Label, Non-Randomized, Mass Balance Study to Investigate the Recovery, Excretion, and Pharmacokinetics of 14C-GSK1265744 Administered as a Single Oral Dose and a Placebo-Controlled, Randomized Study to Describe the Pharmacokinetics of a Supratherapeutic Dose of GSK1265744 in Healthy Adult Subjects
		Status: Enrolling	
	Updated: 5/30/2013
	
	An Study to Investigate the Recovery, Excretion, and Pharmacokinetics of 14C-GSK1265744 Administered as a Single Oral Dose and a Study to Describe the Pharmacokinetics of a Supratherapeutic Dose of GSK1265744 in Healthy Adult Subjects
	
Updated: 5/30/2013
  
  
  	  An Open Label, Non-Randomized, Mass Balance Study to Investigate the Recovery, Excretion, and Pharmacokinetics of 14C-GSK1265744 Administered as a Single Oral Dose and a Placebo-Controlled, Randomized Study to Describe the Pharmacokinetics of a Supratherapeutic Dose of GSK1265744 in Healthy Adult Subjects
		Status: Enrolling	
	Updated: 5/30/2013
Click here to add this to my saved trials
		    
			
	Assessment of the Effects of Enclomiphene Citrate on Bone Mineral Density in Men With Secondary Hypogonadism
	
Updated: 6/4/2013
  
  
  A 12 Month, Single Blind, Placebo Controlled, Phase III Study to Assess the Effects of Enclomiphene Citrate Treatment On Bone Mineral Density in Men With Secondary Hypogonadism
		Status: Enrolling	
	Updated: 6/4/2013
	
	Assessment of the Effects of Enclomiphene Citrate on Bone Mineral Density in Men With Secondary Hypogonadism
	
Updated: 6/4/2013
  
  
  	  A 12 Month, Single Blind, Placebo Controlled, Phase III Study to Assess the Effects of Enclomiphene Citrate Treatment On Bone Mineral Density in Men With Secondary Hypogonadism
		Status: Enrolling	
	Updated: 6/4/2013
Click here to add this to my saved trials
		    
			
	Assessment of the Effects of Enclomiphene Citrate on Bone Mineral Density in Men With Secondary Hypogonadism
	
Updated: 6/4/2013
  
  
  A 12 Month, Single Blind, Placebo Controlled, Phase III Study to Assess the Effects of Enclomiphene Citrate Treatment On Bone Mineral Density in Men With Secondary Hypogonadism
		Status: Enrolling	
	Updated: 6/4/2013
	
	Assessment of the Effects of Enclomiphene Citrate on Bone Mineral Density in Men With Secondary Hypogonadism
	
Updated: 6/4/2013
  
  
  	  A 12 Month, Single Blind, Placebo Controlled, Phase III Study to Assess the Effects of Enclomiphene Citrate Treatment On Bone Mineral Density in Men With Secondary Hypogonadism
		Status: Enrolling	
	Updated: 6/4/2013
Click here to add this to my saved trials
		    
			
	Assessment of the Effects of Enclomiphene Citrate on Bone Mineral Density in Men With Secondary Hypogonadism
	
Updated: 6/4/2013
  
  
  A 12 Month, Single Blind, Placebo Controlled, Phase III Study to Assess the Effects of Enclomiphene Citrate Treatment On Bone Mineral Density in Men With Secondary Hypogonadism
		Status: Enrolling	
	Updated: 6/4/2013
	
	Assessment of the Effects of Enclomiphene Citrate on Bone Mineral Density in Men With Secondary Hypogonadism
	
Updated: 6/4/2013
  
  
  	  A 12 Month, Single Blind, Placebo Controlled, Phase III Study to Assess the Effects of Enclomiphene Citrate Treatment On Bone Mineral Density in Men With Secondary Hypogonadism
		Status: Enrolling	
	Updated: 6/4/2013
Click here to add this to my saved trials
		    
			
	Assessment of the Effects of Enclomiphene Citrate on Bone Mineral Density in Men With Secondary Hypogonadism
	
Updated: 6/4/2013
  
  
  A 12 Month, Single Blind, Placebo Controlled, Phase III Study to Assess the Effects of Enclomiphene Citrate Treatment On Bone Mineral Density in Men With Secondary Hypogonadism
		Status: Enrolling	
	Updated: 6/4/2013
	
	Assessment of the Effects of Enclomiphene Citrate on Bone Mineral Density in Men With Secondary Hypogonadism
	
Updated: 6/4/2013
  
  
  	  A 12 Month, Single Blind, Placebo Controlled, Phase III Study to Assess the Effects of Enclomiphene Citrate Treatment On Bone Mineral Density in Men With Secondary Hypogonadism
		Status: Enrolling	
	Updated: 6/4/2013
Click here to add this to my saved trials
		    
			
	Assessment of the Effects of Enclomiphene Citrate on Bone Mineral Density in Men With Secondary Hypogonadism
	
Updated: 6/4/2013
  
  
  A 12 Month, Single Blind, Placebo Controlled, Phase III Study to Assess the Effects of Enclomiphene Citrate Treatment On Bone Mineral Density in Men With Secondary Hypogonadism
		Status: Enrolling	
	Updated: 6/4/2013
	
	Assessment of the Effects of Enclomiphene Citrate on Bone Mineral Density in Men With Secondary Hypogonadism
	
Updated: 6/4/2013
  
  
  	  A 12 Month, Single Blind, Placebo Controlled, Phase III Study to Assess the Effects of Enclomiphene Citrate Treatment On Bone Mineral Density in Men With Secondary Hypogonadism
		Status: Enrolling	
	Updated: 6/4/2013
Click here to add this to my saved trials
		    
			
	Assessment of the Effects of Enclomiphene Citrate on Bone Mineral Density in Men With Secondary Hypogonadism
	
Updated: 6/4/2013
  
  
  A 12 Month, Single Blind, Placebo Controlled, Phase III Study to Assess the Effects of Enclomiphene Citrate Treatment On Bone Mineral Density in Men With Secondary Hypogonadism
		Status: Enrolling	
	Updated: 6/4/2013
	
	Assessment of the Effects of Enclomiphene Citrate on Bone Mineral Density in Men With Secondary Hypogonadism
	
Updated: 6/4/2013
  
  
  	  A 12 Month, Single Blind, Placebo Controlled, Phase III Study to Assess the Effects of Enclomiphene Citrate Treatment On Bone Mineral Density in Men With Secondary Hypogonadism
		Status: Enrolling	
	Updated: 6/4/2013
Click here to add this to my saved trials
		    
			
	Assessment of the Effects of Enclomiphene Citrate on Bone Mineral Density in Men With Secondary Hypogonadism
	
Updated: 6/4/2013
  
  
  A 12 Month, Single Blind, Placebo Controlled, Phase III Study to Assess the Effects of Enclomiphene Citrate Treatment On Bone Mineral Density in Men With Secondary Hypogonadism
		Status: Enrolling	
	Updated: 6/4/2013
	
	Assessment of the Effects of Enclomiphene Citrate on Bone Mineral Density in Men With Secondary Hypogonadism
	
Updated: 6/4/2013
  
  
  	  A 12 Month, Single Blind, Placebo Controlled, Phase III Study to Assess the Effects of Enclomiphene Citrate Treatment On Bone Mineral Density in Men With Secondary Hypogonadism
		Status: Enrolling	
	Updated: 6/4/2013
Click here to add this to my saved trials
		    
			
	Assessment of the Effects of Enclomiphene Citrate on Bone Mineral Density in Men With Secondary Hypogonadism
	
Updated: 6/4/2013
  
  
  A 12 Month, Single Blind, Placebo Controlled, Phase III Study to Assess the Effects of Enclomiphene Citrate Treatment On Bone Mineral Density in Men With Secondary Hypogonadism
		Status: Enrolling	
	Updated: 6/4/2013
	
	Assessment of the Effects of Enclomiphene Citrate on Bone Mineral Density in Men With Secondary Hypogonadism
	
Updated: 6/4/2013
  
  
  	  A 12 Month, Single Blind, Placebo Controlled, Phase III Study to Assess the Effects of Enclomiphene Citrate Treatment On Bone Mineral Density in Men With Secondary Hypogonadism
		Status: Enrolling	
	Updated: 6/4/2013
Click here to add this to my saved trials
		    
			
	Safety Study of Abatacept to Treat Refractory Sarcoidosis
	
Updated: 6/10/2013
  
  
  Sarcoidosis, Trial of Abatacept in Refractory Disease (STAR). A Prospective Open-Label Trial of Abatacept in Progressive Sarcoidosis
		Status: Enrolling	
	Updated: 6/10/2013
	
	Safety Study of Abatacept to Treat Refractory Sarcoidosis
	
Updated: 6/10/2013
  
  
  	  Sarcoidosis, Trial of Abatacept in Refractory Disease (STAR). A Prospective Open-Label Trial of Abatacept in Progressive Sarcoidosis
		Status: Enrolling	
	Updated: 6/10/2013
Click here to add this to my saved trials
		    
			
	Effects of Standing on Glycemia in Prediabetic Adults
	
Updated: 6/21/2013
  
  
  Acute Effects of Standing on Glycemia in Prediabetic Adults: A Pilot Study
		Status: Enrolling	
	Updated: 6/21/2013
	
	Effects of Standing on Glycemia in Prediabetic Adults
	
Updated: 6/21/2013
  
  
  	  Acute Effects of Standing on Glycemia in Prediabetic Adults: A Pilot Study
		Status: Enrolling	
	Updated: 6/21/2013
Click here to add this to my saved trials
		    
			
	Effects of TNF-alpha Antagonism (Etanercept) in Patients With the Metabolic Syndrome and Psoriasis
	
Updated: 6/25/2013
  
  
  Effects of TNF-alpha Antagonism (Etanercept) in Patients With the Metabolic Syndrome and Psoriasis
		Status: Enrolling	
	Updated: 6/25/2013
	
	Effects of TNF-alpha Antagonism (Etanercept) in Patients With the Metabolic Syndrome and Psoriasis
	
Updated: 6/25/2013
  
  
  	  Effects of TNF-alpha Antagonism (Etanercept) in Patients With the Metabolic Syndrome and Psoriasis
		Status: Enrolling	
	Updated: 6/25/2013
Click here to add this to my saved trials
		    
			
	Insulin Resistance in Non-alcoholic Fatty Liver Disease
	
Updated: 7/8/2013
  
  
  Insulin Resistance in Non-alcoholic Fatty Liver Disease (Protocol Drug Change From Project CDA-2-044-08S)
		Status: Enrolling	
	Updated: 7/8/2013
	
	Insulin Resistance in Non-alcoholic Fatty Liver Disease
	
Updated: 7/8/2013
  
  
  	  Insulin Resistance in Non-alcoholic Fatty Liver Disease (Protocol Drug Change From Project CDA-2-044-08S)
		Status: Enrolling	
	Updated: 7/8/2013
Click here to add this to my saved trials
		    
			
	Does Class of Dietary Fat Affect Insulin Resistance?
	
Updated: 7/11/2013
  
  
  Insulin Resistance and Dietary Fat
		Status: Enrolling	
	Updated: 7/11/2013
	
	Does Class of Dietary Fat Affect Insulin Resistance?
	
Updated: 7/11/2013
  
  
  	  Insulin Resistance and Dietary Fat
		Status: Enrolling	
	Updated: 7/11/2013
Click here to add this to my saved trials
		    
			
	Calcium Homeostasis in Acromegaly: Effect of Surgical/Medical Treatment and Comparison With Nonfunctioning Pituitary Tumors
	
Updated: 7/18/2013
  
  
  Calcium Homeostasis in Acromegaly: Effect of Surgical/Medical Treatment and Comparison With Nonfunctioning Pituitary Tumors.
		Status: Enrolling	
	Updated: 7/18/2013
	
	Calcium Homeostasis in Acromegaly: Effect of Surgical/Medical Treatment and Comparison With Nonfunctioning Pituitary Tumors
	
Updated: 7/18/2013
  
  
  	  Calcium Homeostasis in Acromegaly: Effect of Surgical/Medical Treatment and Comparison With Nonfunctioning Pituitary Tumors.
		Status: Enrolling	
	Updated: 7/18/2013
Click here to add this to my saved trials
		    
			
	Calcium Homeostasis in Acromegaly: Effect of Surgical/Medical Treatment and Comparison With Nonfunctioning Pituitary Tumors
	
Updated: 7/18/2013
  
  
  Calcium Homeostasis in Acromegaly: Effect of Surgical/Medical Treatment and Comparison With Nonfunctioning Pituitary Tumors.
		Status: Enrolling	
	Updated: 7/18/2013
	
	Calcium Homeostasis in Acromegaly: Effect of Surgical/Medical Treatment and Comparison With Nonfunctioning Pituitary Tumors
	
Updated: 7/18/2013
  
  
  	  Calcium Homeostasis in Acromegaly: Effect of Surgical/Medical Treatment and Comparison With Nonfunctioning Pituitary Tumors.
		Status: Enrolling	
	Updated: 7/18/2013
Click here to add this to my saved trials
		    
			
	Moderate Intensity Exercise and Phenylketonuria
	
Updated: 7/19/2013
  
  
  The Effects of an Acute Bout of Moderate Intensity Exercise on Plasma Amino Acids in Subjects With Phenylketonuria
		Status: Enrolling	
	Updated: 7/19/2013
	
	Moderate Intensity Exercise and Phenylketonuria
	
Updated: 7/19/2013
  
  
  	  The Effects of an Acute Bout of Moderate Intensity Exercise on Plasma Amino Acids in Subjects With Phenylketonuria
		Status: Enrolling	
	Updated: 7/19/2013
Click here to add this to my saved trials
		    
			
	Examining the Effects of Antipsychotic Medications on Insulin Sensitivity
	
Updated: 8/6/2013
  
  
  Acute Impact of Antipsychotics on Insulin Sensitivity: A Novel Human Model
		Status: Enrolling	
	Updated: 8/6/2013
	
	Examining the Effects of Antipsychotic Medications on Insulin Sensitivity
	
Updated: 8/6/2013
  
  
  	  Acute Impact of Antipsychotics on Insulin Sensitivity: A Novel Human Model
		Status: Enrolling	
	Updated: 8/6/2013
Click here to add this to my saved trials
		    
			
	Ziprasidone for Improving Insulin Sensitivity in People With Schizophrenia Who Are at Risk for Diabetes
	
Updated: 8/6/2013
  
  
  The Metabolic Syndrome in Patients With Schizophrenia
		Status: Enrolling	
	Updated: 8/6/2013
	
	Ziprasidone for Improving Insulin Sensitivity in People With Schizophrenia Who Are at Risk for Diabetes
	
Updated: 8/6/2013
  
  
  	  The Metabolic Syndrome in Patients With Schizophrenia
		Status: Enrolling	
	Updated: 8/6/2013
Click here to add this to my saved trials
		    
			
	Feasibility Study Assessing the Ability of an Insulin Pump-controlling Algorithm to Minimize Hypoglycemia
	
Updated: 8/8/2013
  
  
  Feasibility Study Assessing the Ability of an Insulin Pump-controlling Algorithm to Minimize Hypoglycemia in Patients With Type 1 Diabetes in a Clinical Research Setting
		Status: Enrolling	
	Updated: 8/8/2013
	
	Feasibility Study Assessing the Ability of an Insulin Pump-controlling Algorithm to Minimize Hypoglycemia
	
Updated: 8/8/2013
  
  
  	  Feasibility Study Assessing the Ability of an Insulin Pump-controlling Algorithm to Minimize Hypoglycemia in Patients With Type 1 Diabetes in a Clinical Research Setting
		Status: Enrolling	
	Updated: 8/8/2013
Click here to add this to my saved trials
		    
			
	Regulating Efficacy and Wellness in Diabetes
	
Updated: 8/9/2013
  
  
  Social Cognitive and Neuropsychological Influences on Physical Activity Behavior in Type II Diabetes
		Status: Enrolling	
	Updated: 8/9/2013
	
	Regulating Efficacy and Wellness in Diabetes
	
Updated: 8/9/2013
  
  
  	  Social Cognitive and Neuropsychological Influences on Physical Activity Behavior in Type II Diabetes
		Status: Enrolling	
	Updated: 8/9/2013
Click here to add this to my saved trials
		    
			
	Evaluation of the Pharmacokinetics and Safety of Androxal in Male Subjects With Impaired Hepatic Function
	
Updated: 8/14/2013
  
  
  An Open Label Study to Evaluate the Pharmacokinetics and Safety Profile of Androxal in Male Subjects With Impaired Hepatic Function
		Status: Enrolling	
	Updated: 8/14/2013
	
	Evaluation of the Pharmacokinetics and Safety of Androxal in Male Subjects With Impaired Hepatic Function
	
Updated: 8/14/2013
  
  
  	  An Open Label Study to Evaluate the Pharmacokinetics and Safety Profile of Androxal in Male Subjects With Impaired Hepatic Function
		Status: Enrolling	
	Updated: 8/14/2013
Click here to add this to my saved trials
		    
			
	Dairy Fat as a Mediator of Vitamin E Adequacy in Individuals With Metabolic Syndrome
	
Updated: 8/27/2013
  
  
  Dairy Fat as a Mediator of Vitamin E Adequacy in Individuals With Metabolic Syndrome
		Status: Enrolling	
	Updated: 8/27/2013
	
	Dairy Fat as a Mediator of Vitamin E Adequacy in Individuals With Metabolic Syndrome
	
Updated: 8/27/2013
  
  
  	  Dairy Fat as a Mediator of Vitamin E Adequacy in Individuals With Metabolic Syndrome
		Status: Enrolling	
	Updated: 8/27/2013
Click here to add this to my saved trials
		    
			
	Effect of Exercise on Insulin Resistance
	
Updated: 9/10/2013
  
  
  Effect of Exercise on Insulin Resistance
		Status: Enrolling	
	Updated: 9/10/2013
	
	Effect of Exercise on Insulin Resistance
	
Updated: 9/10/2013
  
  
  	  Effect of Exercise on Insulin Resistance
		Status: Enrolling	
	Updated: 9/10/2013
Click here to add this to my saved trials
		    
			
	Blackberry Flavonoid Absorption and Effects on Intestinal Bacteria
	
		Status: Enrolling	
	
Updated: 9/12/2013
  
  
  Updated: 9/12/2013
	
	Blackberry Flavonoid Absorption and Effects on Intestinal Bacteria
	
		Status: Enrolling	
	
Updated: 9/12/2013
  
  
  	  Updated: 9/12/2013
Click here to add this to my saved trials
		    
			
	A Study of Ejaculatory Dysfunction in Men With Low Testosterone Levels
	
Updated: 9/13/2013
  
  
  A Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Study to Explore the Impact of Testosterone Solution 2% on Symptoms of Ejaculatory Dysfunction in Men With Testosterone Deficiency
		Status: Enrolling	
	Updated: 9/13/2013
	
	A Study of Ejaculatory Dysfunction in Men With Low Testosterone Levels
	
Updated: 9/13/2013
  
  
  	  A Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Study to Explore the Impact of Testosterone Solution 2% on Symptoms of Ejaculatory Dysfunction in Men With Testosterone Deficiency
		Status: Enrolling	
	Updated: 9/13/2013
Click here to add this to my saved trials
		    
			
	A Study of Ejaculatory Dysfunction in Men With Low Testosterone Levels
	
Updated: 9/13/2013
  
  
  A Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Study to Explore the Impact of Testosterone Solution 2% on Symptoms of Ejaculatory Dysfunction in Men With Testosterone Deficiency
		Status: Enrolling	
	Updated: 9/13/2013
	
	A Study of Ejaculatory Dysfunction in Men With Low Testosterone Levels
	
Updated: 9/13/2013
  
  
  	  A Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Study to Explore the Impact of Testosterone Solution 2% on Symptoms of Ejaculatory Dysfunction in Men With Testosterone Deficiency
		Status: Enrolling	
	Updated: 9/13/2013
Click here to add this to my saved trials
		    
			
	A Study of Ejaculatory Dysfunction in Men With Low Testosterone Levels
	
Updated: 9/13/2013
  
  
  A Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Study to Explore the Impact of Testosterone Solution 2% on Symptoms of Ejaculatory Dysfunction in Men With Testosterone Deficiency
		Status: Enrolling	
	Updated: 9/13/2013
	
	A Study of Ejaculatory Dysfunction in Men With Low Testosterone Levels
	
Updated: 9/13/2013
  
  
  	  A Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Study to Explore the Impact of Testosterone Solution 2% on Symptoms of Ejaculatory Dysfunction in Men With Testosterone Deficiency
		Status: Enrolling	
	Updated: 9/13/2013
Click here to add this to my saved trials
		    
			
	A Study of Ejaculatory Dysfunction in Men With Low Testosterone Levels
	
Updated: 9/13/2013
  
  
  A Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Study to Explore the Impact of Testosterone Solution 2% on Symptoms of Ejaculatory Dysfunction in Men With Testosterone Deficiency
		Status: Enrolling	
	Updated: 9/13/2013
	
	A Study of Ejaculatory Dysfunction in Men With Low Testosterone Levels
	
Updated: 9/13/2013
  
  
  	  A Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Study to Explore the Impact of Testosterone Solution 2% on Symptoms of Ejaculatory Dysfunction in Men With Testosterone Deficiency
		Status: Enrolling	
	Updated: 9/13/2013
Click here to add this to my saved trials
		    
			
	A Trial to Investigate the Bioequivalence of Norditropin® (Somatropin) Versus Genotropin® (Somatropin) in Healthy Adult Subjects
	
Updated: 9/17/2013
  
  
  A Trial to Investigate the Bioequivalence of Norditropin® (Somatropin) Versus Genotropin® (Somatropin) in Healthy Adult Subjects
		Status: Enrolling	
	Updated: 9/17/2013
	
	A Trial to Investigate the Bioequivalence of Norditropin® (Somatropin) Versus Genotropin® (Somatropin) in Healthy Adult Subjects
	
Updated: 9/17/2013
  
  
  	  A Trial to Investigate the Bioequivalence of Norditropin® (Somatropin) Versus Genotropin® (Somatropin) in Healthy Adult Subjects
		Status: Enrolling	
	Updated: 9/17/2013
Click here to add this to my saved trials
		    
			
	Effects of Thyroid Hormone Enzyme Blocking on Hypothyroidism
	
Updated: 10/5/2013
  
  
  Effects of Pharmacologic Block of Type-1 Deiodinase on Thyroid Hormone Action and on the Circulating Levels of T3 in Hypothyroid Patients
		Status: Enrolling	
	Updated: 10/5/2013
	
	Effects of Thyroid Hormone Enzyme Blocking on Hypothyroidism
	
Updated: 10/5/2013
  
  
  	  Effects of Pharmacologic Block of Type-1 Deiodinase on Thyroid Hormone Action and on the Circulating Levels of T3 in Hypothyroid Patients
		Status: Enrolling	
	Updated: 10/5/2013
Click here to add this to my saved trials
		    
			
	Pegvisomant With Glucagon Test to Assess for Adult Growth Hormone Deficiency
	
Updated: 10/23/2013
  
  
  Effects of Pegvisomant-Priming With the Glucagon Stimulation Test in Assessing GH and Cortisol Reserve in Adults: a Randomized Proof-of-Concept Pilot Study
		Status: Enrolling	
	Updated: 10/23/2013
	
	Pegvisomant With Glucagon Test to Assess for Adult Growth Hormone Deficiency
	
Updated: 10/23/2013
  
  
  	  Effects of Pegvisomant-Priming With the Glucagon Stimulation Test in Assessing GH and Cortisol Reserve in Adults: a Randomized Proof-of-Concept Pilot Study
		Status: Enrolling	
	Updated: 10/23/2013
Click here to add this to my saved trials
		    
			
	Triple Blockade of the Renin Angiotensin Aldosterone System in Diabetic (Type 1&2) Proteinuric Patients
	
Updated: 10/24/2013
  
  
  Study of Triple Blockade of the Renin Angiotensin Aldosterone System (RAAS) in Diabetic (Type 1&2) Proteinuric Patients With (ACE-, ARB, DRI)
		Status: Enrolling	
	Updated: 10/24/2013
	
	Triple Blockade of the Renin Angiotensin Aldosterone System in Diabetic (Type 1&2) Proteinuric Patients
	
Updated: 10/24/2013
  
  
  	  Study of Triple Blockade of the Renin Angiotensin Aldosterone System (RAAS) in Diabetic (Type 1&2) Proteinuric Patients With (ACE-, ARB, DRI)
		Status: Enrolling	
	Updated: 10/24/2013
Click here to add this to my saved trials